nipradilol has been researched along with Glaucoma, Suspect in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, I; Orihashi, M; Shima, Y; Tsuneki, H | 1 |
Araie, M; Azuma, I; Kanno, M; Kitazawa, Y; Masuda, K; Ogawa, N; Ohdo, S; Shiose, Y; Takase, M | 2 |
Araie, M; Kanno, M; Koibuchi, H; Masuda, K | 1 |
3 trial(s) available for nipradilol and Glaucoma, Suspect
Article | Year |
---|---|
Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Propanolamines; Timolol; Vasodilator Agents | 2006 |
Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Propanolamines; Timolol | 2006 |
Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aqueous Humor; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Propanolamines; Timolol | 2000 |
1 other study(ies) available for nipradilol and Glaucoma, Suspect
Article | Year |
---|---|
Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits.
Topics: Animals; Drug Therapy, Combination; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Propanolamines; Prostaglandins F, Synthetic; Rabbits | 2005 |